Pazdur Tells of FDA Turmoil; Surgeon's Data Questioned; MAHA's Supplement Boom

(MedPage Today) — Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week.
Pazdur Tells of FDA Turmoil
Former FDA drug chief Richard Pazdur, MD, warned of “chaos…

Source link : https://www.medpagetoday.com/special-reports/features/119417

Author :

Publish date : 2026-01-14 15:55:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Pazdur Tells of FDA Turmoil; Surgeon’s Data Questioned; MAHA’s Supplement Boom

Fewer Americans Sign Up for Obamacare Plans as Costs Spike

Sinking river deltas put millions at risk of flooding

Related Posts

Floaters May Signal Urgent Need for Specialty Attention

‘The 1980s Called’: CMS Rule Aims to Phase Out Fax Machines for Health Claims

Brain Waves During Sleep Predict Dementia Risk

Method for More Anatomically Targeted CPR Comes Up Short

Fall-Related Eye Injuries Reveal Hidden Health Risks

Trial Questions Fluid Intake Targets for Preventing Urinary Stone Recurrence

Floaters May Signal Urgent Need for Specialty Attention

‘The 1980s Called’: CMS Rule Aims to Phase Out Fax Machines for Health Claims

Brain Waves During Sleep Predict Dementia Risk

Method for More Anatomically Targeted CPR Comes Up Short

Fall-Related Eye Injuries Reveal Hidden Health Risks

Trial Questions Fluid Intake Targets for Preventing Urinary Stone Recurrence

Europe Does Better Than U.S. in Treating Spondyloarthritis, Survey Data Suggest

Nearly 1 in 5 Pediatric Hospital Deaths in the U.S. Involve Sepsis

Categories

Archives